RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:I Dont Understand.....Longholder99, I could not agree more.
Now let's place a name on these bashers.
Goosebear and Mikee3003, these two clowns pretend to be cancer survivors, and keep bashing a company that could one day save there own live, go figure!
DumDum, is not very dangerous, he loose credibility by writing to many meaningless posts.
Infinity, this one will try to be your friend, just to deceive you and discredit management.
NotaPoop, he used to be the most dangerous one, but lately he seem to have hit the panic button, maybe he feel good news are just around the corner and the FDA BTD approval is unavoidable.
They all use the same modus operandi, they almost exclusively talk about delays and PP, but they all fail to name a single company that did better than Theralase under similar conditions.The road to FDA approval is not a straight line. Especially when a company like Theralase is trying to get through the FDA approval process with a revolutionnary PDT treatment like Ruvidar.
Theralase is in a phase11 trial with exceptional data, and nobody before Theralase has reached a FDA phase11 trial with a PDT treatment and with the
best duration of response data of all FDA approved treatments for BCG resistant patients.
And Theralase did it with only 300million shares out.
Talk about a great feat.
Talk about great management. Yes there could be more PP, and yes there could be more delays, delays and PP are part of the long FDA approval process for new and disruptive treatments.
But the GOLDEN GOOSE at the end of the road will be worth it.
Longholder99 wrote: Bashers, armchair quarterbacks, internet "MBA'S". All a joke and obvious in their intent to either scare the weak hands or cause discontent so new investors run from the stupidity. Possibly in many cases the same person logging in from different accounts. All easily ignored while the true investors talk about the tech and the market cap we hope to enjoy. Many thanks to our regular strong contributors.